These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26899300)

  • 1. Carfilzomib-induced cardiotoxicity mitigated by dexrazoxane through inhibition of hypertrophic gene expression and oxidative stress in rats.
    Al-Harbi NO
    Toxicol Mech Methods; 2016; 26(3):189-95. PubMed ID: 26899300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats.
    Imam F; Al-Harbi NO; Al-Harbi MM; Ansari MA; Almutairi MM; Alshammari M; Almukhlafi TS; Ansari MN; Aljerian K; Ahmad SF
    Toxicol Mech Methods; 2016 Nov; 26(9):700-708. PubMed ID: 27785949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rutin Attenuates Carfilzomib-Induced Cardiotoxicity Through Inhibition of NF-κB, Hypertrophic Gene Expression and Oxidative Stress.
    Imam F; Al-Harbi NO; Al-Harbia MM; Korashy HM; Ansari MA; Sayed-Ahmed MM; Nagi MN; Iqbal M; Khalid Anwer M; Kazmi I; Afzal M; Bahashwan S
    Cardiovasc Toxicol; 2017 Jan; 17(1):58-66. PubMed ID: 26707720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac protective effects of dexrazoxane on animal cardiotoxicity model induced by anthracycline combined with trastuzumab is associated with upregulation of calpain-2.
    Zhang S; Meng T; Liu J; Zhang X; Zhang J
    Medicine (Baltimore); 2015 Jan; 94(4):e445. PubMed ID: 25634181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
    Imondi AR; Della Torre P; Mazué G; Sullivan TM; Robbins TL; Hagerman LM; Podestà A; Pinciroli G
    Cancer Res; 1996 Sep; 56(18):4200-4. PubMed ID: 8797592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rutin inhibits carfilzomib-induced oxidative stress and inflammation via the NOS-mediated NF-κB signaling pathway.
    Al-Harbi NO; Imam F; Al-Harbi MM; Al-Shabanah OA; Alotaibi MR; As Sobeai HM; Afzal M; Kazmi I; Al Rikabi AC
    Inflammopharmacology; 2019 Aug; 27(4):817-827. PubMed ID: 30600471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zingerone Attenuates Carfilzomib-Induced Cardiotoxicity in Rats through Oxidative Stress and Inflammatory Cytokine Network.
    Alam MF; Hijri SI; Alshahrani S; Alqahtani SS; Jali AM; Ahmed RA; Adawi MM; Algassmi SM; Shaheen ES; Moni SS; Anwer T
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against doxorubicin-induced cardiotoxicity in weanling rats by dexrazoxane.
    Della Torre P; Mazué G; Podestà A; Moneta D; Sammartini U; Imondi AR
    Cancer Chemother Pharmacol; 1999; 43(2):151-6. PubMed ID: 9923821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective effect of dexrazoxane in a rat model of myocardial infarction: anti-apoptosis and promoting angiogenesis.
    Zhou L; Sung RY; Li K; Pong NH; Xiang P; Shen J; Ng PC; Chen Y
    Int J Cardiol; 2011 Oct; 152(2):196-201. PubMed ID: 20692056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study.
    QuanJun Y; GenJin Y; LiLi W; YongLong H; Yan H; Jie L; JinLu H; Jin L; Run G; Cheng G
    PLoS One; 2017; 12(1):e0169567. PubMed ID: 28072830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxyphenbutazone ameliorates carfilzomib induced cardiotoxicity in rats via inhibition of oxidative free radical burst and NF-κB/IκB-α pathway.
    Imam F; Afzal M; Ghaboura N; Saad Alharbi K; Kazmi I; Alshehri S; Saeed Alqarni S; Guven E
    Saudi Pharm J; 2024 Jan; 32(1):101926. PubMed ID: 38226350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible antineoplastic potential of selective, irreversible proteasome inhibitor, carfilzomib on chemically induced hepatocarcinogenesis in rats.
    Mansour MA; Aljoufi MA; Al-Hosaini K; Al-Rikabi AC; Nagi MN
    J Biochem Mol Toxicol; 2014 Sep; 28(9):400-6. PubMed ID: 24861196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotection by dexrazoxane in rats treated with doxorubicin and paclitaxel.
    Della Torre P; Imondi AR; Bernardi C; Podestà A; Moneta D; Riflettuto M; Mazué G
    Cancer Chemother Pharmacol; 1999; 44(2):138-42. PubMed ID: 10412948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of cardiotoxicity of gefitinib in vivo and in vitro rat cardiomyocyte: Role of apoptosis and oxidative stress.
    Korashy HM; Attafi IM; Ansari MA; Assiri MA; Belali OM; Ahmad SF; Al-Alallah IA; Anazi FE; Alhaider AA
    Toxicol Lett; 2016 Jun; 252():50-61. PubMed ID: 27084042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ellagic acid protects against arsenic trioxide-induced cardiotoxicity in rat.
    Hemmati AA; Olapour S; Varzi HN; Khodayar MJ; Dianat M; Mohammadian B; Yaghooti H
    Hum Exp Toxicol; 2018 Apr; 37(4):412-419. PubMed ID: 28474970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
    Mantawy EM; El-Bakly WM; Esmat A; Badr AM; El-Demerdash E
    Eur J Pharmacol; 2014 Apr; 728():107-18. PubMed ID: 24509133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoquinone Ameliorates Carfilzomib-Induced Renal Impairment by Modulating Oxidative Stress Markers, Inflammatory/Apoptotic Mediators, and Augmenting Nrf2 in Rats.
    Qadri MM; Alam MF; Khired ZA; Alaqi RO; Khardali AA; Alasmari MM; Alrashah ASS; Muzafar HMA; Qahl AM
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats.
    Lebrecht D; Geist A; Ketelsen UP; Haberstroh J; Setzer B; Walker UA
    Br J Pharmacol; 2007 Jul; 151(6):771-8. PubMed ID: 17519947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model.
    Xiang P; Deng HY; Li K; Huang GY; Chen Y; Tu L; Ng PC; Pong NH; Zhao H; Zhang L; Sung RY
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):343-9. PubMed ID: 18379782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished molecular response to doxorubicin and loss of cardioprotective effect of dexrazoxane in Egr-1 deficient female mice.
    Saadane N; Yue P; Alpert L; Mitmaker B; Kirby GM; Chalifour LE
    Can J Physiol Pharmacol; 2001 Jun; 79(6):533-44. PubMed ID: 11430591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.